GlassScriptPhysician profile
Brandy N Glascock
NPI 1578884995
$1,670.79
in general payments reported to CMS, 2019-2025
17 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $63.34 · 2021: $52.87 · 2022: $347 · 2023: $359 · 2024: $197 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $699.77 | 2022-2025 | |
| Pfizer INC. | $255.07 | 2019-2025 | |
| Glaxosmithkline, LLC. | $200.85 | 2019-2023 | Shingrix, Arexvy, Bexsero |
| Dexcom, INC. | $120.51 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $76.27 | 2019-2025 | Prolia, Evenity |
| Novo Nordisk INC | $50.21 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $46.73 | 2024 | Airsupra |
| Astellas Pharma US INC | $42.92 | 2021-2022 | |
| Medtronic, INC. | $41.75 | 2022-2023 | Na |
| Allergan, INC. | $35.44 | 2019-2020 | |
| Abbott Laboratories | $18.79 | 2019 | |
| Axsome Therapeutics, INC. | $17.03 | 2025 | Symbravo |
| Lilly USA, LLC | $15.23 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.92 | 2020 | |
| Merck Sharp & Dohme LLC | $12.55 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $12.46 | 2019 | |
| Amarin Pharma, INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Glascock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.